DRMA ▼ -5.7% - Dermata Therapeutics, Inc. $DRMA - Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial 29-OCT-2026 04:10 PM ET